Clinical Report: Identification of Risk Factors in Various Cancer Types Using Explainable AI Techniques
Overview
This report presents a novel method for risk stratification in cancer using explainable AI techniques, demonstrating its effectiveness in identifying prognostically distinct patient groups. The method was validated through simulation experiments and applied to multiple myeloma and non-small cell lung cancer datasets, revealing clinically meaningful features that align with established risk factors.
Background
Risk stratification is crucial in oncology for guiding treatment decisions and optimizing resource allocation. Traditional survival analysis methods often lack the clarity needed for practical application in clinical settings. The introduction of explainable AI techniques offers a promising avenue for enhancing patient grouping based on risk factors, potentially improving treatment personalization.
Data Highlights
The study evaluated the proposed method on two cancer types: multiple myeloma (MM) using the CoMMpass dataset and non-small cell lung cancer (NSCLC) using the Lung1 dataset. Findings were validated with external datasets, reinforcing the method's reliability.
Key Findings
The novel method optimizes survival heterogeneity across patient clusters using any neural network architecture.
Clinically meaningful features were identified that correlate with established risk factors in both MM and NSCLC.
External validation of findings in MM was conducted using the GMMG-MM5 study dataset.
The NSCLC findings were validated with institutional data, supporting the method's utility.
This approach provides a model-agnostic framework for discovering novel prognostic signatures across diverse data types.
Clinical Implications
The findings suggest that integrating explainable AI into clinical workflows can enhance risk stratification and treatment personalization in oncology. Clinicians may leverage these insights to make more informed decisions based on patient-specific prognostic markers.
Conclusion
The application of explainable AI techniques in cancer risk stratification represents a significant advancement in clinical decision-making. This model-agnostic approach has the potential to transform how oncologists assess and manage patient risk profiles.
by Maximilian Ferle, Jonas Ader, Thomas Wiemers, Nora Grieb, Beatrice Berneck, Adrian Lindenmeyer, Hartmut Goldschmidt, Elias K. Mai, Uta Bertsch, Hans-Jonas Meyer, Thomas Neumuth, Markus Kreuz, Kristin Reiche, Maximilian Merz
